What We Know and Don’t Know About the COVID-19 OTC Test Kit Requirement
Following the release of the Departments of Labor, Health and Human Services (HHS) and the Treasury (collectively, the Departments) FAQ Part 51, a significant number of unanswered questions remain regarding the coverage of over-the-counter (OTC) COVID-19 tests.
In addition, we are seeing insurance carriers, third-party administrators (TPAs) and pharmacy benefit managers (PBMs) implement solutions that differ based on varying interpretations of the guidance, which can create additional confusion for plan sponsors, who must make decisions regarding how their plans should be amended to comply with the new coverage requirements.
In this webinar, the Brown & Brown Regulatory and Legislative Strategy Group will discuss some frequently asked questions. The team will outline questions where some guidance may exist and questions that will require further clarification from the Departments.
Topics covered will include:
- Potential notice requirements
- Whether plan sponsors can increase employee contributions in
response to the new requirement - Claim payment timelines
- What ambiguities still exist?
Attend & Earn 1.0 SHRM Credit
Presented by the Brown & Brown Regulatory & Legislative Strategy Group.
REGISTER HERE
DISCLAIMER: Brown & Brown, Inc. and all its affiliates, do not provide legal, regulatory or tax guidance, or advice. If legal advice counsel or representation is needed, the services of a legal professional should be sought. The information in this document is intended to provide a general overview of the topics and services contained herein. Brown & Brown, Inc. and all its affiliates, make no representation or warranty as to the accuracy or completeness of the document and undertakes no obligation to update or revise the document based upon new information or future changes.
